2023-507529-41-00已完成1 期
MK-1084 Single and Multiple Dose Healthy Participant Study
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Julie Fiore
Scientific
Merck Sharp & Dohme LLC
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)NCT07266818Merck Sharp & Dohme LLC30
招募中
1 期
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid TumorsBreast CancerLung CancerNCT07274852Sichuan Baili Pharmaceutical Co., Ltd.22
已完成
1 期
QTc Assessment in a Single-Dose Study of Hydronidone CapsulesHepatic FibrosisNCT07263152Beijing Continent Pharmaceutical Co, Ltd.48
进行中（未招募）
2 期
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)NCT07266090Viatris Pharmaceuticals Co., Ltd.15
已完成
1 期
Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mgNCT07266766Humanis Saglık Anonim Sirketi40